Is It Justifiable to Move the Grade-1 Ki67 Index Cut-Off from 3% to 5% for Pancreatic Neuroendocrine Tumors as Has Been Proposed? The Cases That Fall to 3-5% Category Have Clinicopathologic Characteristics Closer to Those > 5%


Reid M., Balci S., BAĞCI ÇULÇİ P. , Saka B., Pehlivanoglu B., ERBARUT SEVEN İ. , ...More

109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Los-Angeles, Chile, 29 February - 05 March 2020, vol.33, pp.1673 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 33
  • City: Los-Angeles
  • Country: Chile
  • Page Numbers: pp.1673